Literature DB >> 27994185

In silico characterization of functional SNP within the oestrogen receptor gene.

Maha Rebaï1, Ahmed Rebaï.   

Abstract

Single-nucleotide polymorphism (SNP) association studies have become crucial in uncovering the genetic correlations of genomic variants with complex diseases, quantitative traits and physiological responses to drugs. However, the identification of SNPs responsible for specific phenotypes is a difficult problem to solve, requiring multiple testing of hundreds or thousands of SNPs in candidate genes. In this study, we performed an analysis of the genetic variations that can alter the structure and function of oestrogen receptor α using different computational tools. Among the nonsynonymous SNPs, a total of four SNPs were found to be damaging by both a sequence homology-based tool (SIFT) and a structural homology-based method (polyphen-2, SNAP), as well as by the ESEfinder program, and one nonsense nsSNP was found. For noncoding SNPs, we found that one SNP in 5' UTR may potentially change protein expression level, nine SNPs were found to affect miRNA binding site and 28 SNPs might affect transcriptional regulation of the ESR1 gene. Reviewing the literature, 89 SNPs were found to be functional among which only four were located in exons.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27994185     DOI: 10.1007/s12041-016-0707-1

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  67 in total

1.  Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity.

Authors:  G Speer; K Cseh; G Winkler; P Vargha; E Braun; I Takács; P Lakatos
Journal:  Eur J Endocrinol       Date:  2001-04       Impact factor: 6.664

Review 2.  Gain-of-glycosylation mutations.

Authors:  Guillaume Vogt; Benoît Vogt; Nadia Chuzhanova; Karin Julenius; David N Cooper; Jean-Laurent Casanova
Journal:  Curr Opin Genet Dev       Date:  2007-04-30       Impact factor: 5.578

3.  T29C genotype polymorphism of estrogen receptor alpha is associated with initial response to interferon-alpha therapy in chronic hepatitis B patients.

Authors:  Ting-Ting Zhang; Zhen-Hua Zhang; Yu-Feng Gao; Ya-Fei Zhang; Dong-Liang Yang; Xu Li
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2010-06

4.  Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men.

Authors:  Tomoko Sonoda; Hiromu Suzuki; Mitsuru Mori; Taiji Tsukamoto; Akira Yokomizo; Seiji Naito; Kiyohide Fujimoto; Yoshihiko Hirao; Naoto Miyanaga; Hideyuki Akaza
Journal:  Eur J Cancer Prev       Date:  2010-03       Impact factor: 2.497

5.  Polymorphism of alpha-estrogen receptor and aryl hydrocarbon receptor genes in dementia patients in Shanghai suburb.

Authors:  Guo-Fang Lin; Qing-Wen Ma; Dong-Sheng Zhang; Yong-Lin Zha; Ke-Jian Lou; Jian-Hua Shen
Journal:  Acta Pharmacol Sin       Date:  2003-07       Impact factor: 6.150

6.  Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis.

Authors:  Michael B Boffa; Deborah Maret; Jeffrey D Hamill; Nazareth Bastajian; Paul Crainich; Nancy S Jenny; Zhonghua Tang; Elizabeth M Macy; Russell P Tracy; Rendrik F Franco; Michael E Nesheim; Marlys L Koschinsky
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

Review 7.  Candidate gene association studies: a comprehensive guide to useful in silico tools.

Authors:  Radhika Patnala; Judith Clements; Jyotsna Batra
Journal:  BMC Genet       Date:  2013-05-09       Impact factor: 2.797

8.  The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer.

Authors:  William Tapper; Victoria Hammond; Sue Gerty; Sarah Ennis; Peter Simmonds; Andrew Collins; Diana Eccles
Journal:  Breast Cancer Res       Date:  2008-12-18       Impact factor: 6.466

9.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

10.  SNAP: predict effect of non-synonymous polymorphisms on function.

Authors:  Yana Bromberg; Burkhard Rost
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  3 in total

1.  The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies.

Authors:  Berry Button; Sarah Croessmann; David Chu; D Marc Rosen; Daniel J Zabransky; W Brian Dalton; Karen Cravero; Kelly Kyker-Snowman; Ian Waters; Swathi Karthikeyan; Eric S Christenson; Josh Donaldson; Tasha Hunter; Lauren Dennison; Cody Ramin; Betty May; Richard Roden; Dana Petry; Deborah K Armstrong; Kala Visvanathan; Ben Ho Park
Journal:  Breast Cancer Res Treat       Date:  2018-12-17       Impact factor: 4.872

2.  Increased frequency of ESR1 mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitor.

Authors:  Kaoru Takeshima; Tetsu Hayashida; Hinako Maeda; Ayako Nakashoji; Takamichi Yokoe; Tomoko Seki; Maiko Takahashi; Yuko Kitagawa
Journal:  Oncol Lett       Date:  2020-05-22       Impact factor: 2.967

3.  R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.

Authors:  Tomer Boldes; Keren Merenbakh-Lamin; Shani Journo; Eliya Shachar; Doron Lipson; Adva Yeheskel; Metsada Pasmanik-Chor; Tami Rubinek; Ido Wolf
Journal:  BMC Cancer       Date:  2020-06-08       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.